Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jin-Hun | - |
dc.contributor.author | Chang, Jeong-Soo | - |
dc.contributor.author | El-Gamal, Mohammed I. | - |
dc.contributor.author | Choi, Won-Kyoung | - |
dc.contributor.author | Lee, Woong San | - |
dc.contributor.author | Chung, Hye Jin | - |
dc.contributor.author | Kim, Hyun-Il | - |
dc.contributor.author | Cho, Young-Jin | - |
dc.contributor.author | Lee, Bong Sang | - |
dc.contributor.author | Jeon, Hong-Ryeol | - |
dc.contributor.author | Lee, Yong Sup | - |
dc.contributor.author | Choi, Young Wook | - |
dc.contributor.author | Lee, Jaehwi | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2024-01-20T18:31:19Z | - |
dc.date.available | 2024-01-20T18:31:19Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2010-10-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/131010 | - |
dc.description.abstract | Synthesis of novel amides and esters prodrugs of olmesartan is described. Their in vitro stability in rat plasma was tested. The results showed that the ester derivative IIa with n-octyl substituted dioxolone moiety was rapidly converted into olmesartan within 30 min. The pharmacokinetic parameters of IIa were studied and compared with those of olmesartan medoxomil. Compound IIa is proposed to be a promising prodrug of olmesartan. (C) 2010 Published by Elsevier Ltd. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | ANGIOTENSIN-CONVERTING ENZYME | - |
dc.subject | II RECEPTOR ANTAGONISTS | - |
dc.subject | BLOCKER | - |
dc.subject | MEDOXOMIL | - |
dc.subject | RENIN | - |
dc.title | Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2010.07.089 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.20, no.19, pp.5895 - 5899 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 20 | - |
dc.citation.number | 19 | - |
dc.citation.startPage | 5895 | - |
dc.citation.endPage | 5899 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000281735600064 | - |
dc.identifier.scopusid | 2-s2.0-77957561249 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | ANGIOTENSIN-CONVERTING ENZYME | - |
dc.subject.keywordPlus | II RECEPTOR ANTAGONISTS | - |
dc.subject.keywordPlus | BLOCKER | - |
dc.subject.keywordPlus | MEDOXOMIL | - |
dc.subject.keywordPlus | RENIN | - |
dc.subject.keywordAuthor | Antihypertensive | - |
dc.subject.keywordAuthor | Olmesartan | - |
dc.subject.keywordAuthor | Olmesartan medoxomil | - |
dc.subject.keywordAuthor | Prodrug | - |
dc.subject.keywordAuthor | Amide | - |
dc.subject.keywordAuthor | Ester | - |
dc.subject.keywordAuthor | Pharmacokinetics | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.